|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 144 studies with search of: | Sulfato de abacavir OR Ziagen[TREATMENT] AND HIV [CONDITION] |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks
|
||||
| 2 | Completed |
A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients
|
||||
| 3 | Unknown † |
Raltegravir Switch for Toxicity or Adverse Events
|
||||
| 4 | Completed |
New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects
|
||||
| 5 | Unknown † |
Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment
|
||||
| 6 |
Completed
Has Results |
Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection
|
||||
| 7 | Completed |
Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected Subjects
|
||||
| 8 | Terminated |
Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya
|
||||
| 9 | Recruiting |
Treatment Options for Protease Inhibitor-exposed Children
|
||||
| 10 | Completed |
A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults
|
||||
| 11 |
Completed
Has Results |
Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV
|
||||
| 12 | Recruiting |
Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya
|
||||
| 13 | Unknown † |
Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)
|
||||
| 14 | Unknown † |
Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients
|
||||
| 15 | Completed |
A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study)
|
||||
| 16 | Unknown † |
A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women
|
||||
| 17 | Completed |
Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDI+TDF With ABC+3TC
|
||||
| 18 | Completed |
Efficacy and Safety of Switching From Retrovir to Tenofovir or Abacavir in HIV-infected Patients
|
||||
| 19 | Completed |
Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily
|
||||
| 20 | Completed |
A Study of 1592U89 in HIV-Infected Children
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|